Parnax Lab Limited reported unaudited standalone and consolidated earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, on standalone basis, the company reported total income from operations (net) of INR 71.813 million. Profit from operations before other income, finance cost and exceptional items were INR 10.285 million compared to loss from operations before other income, finance cost and exceptional items of INR 0.240 million a year ago. Profit before ordinary activities before tax was INR 7.370 million against loss before ordinary activities before tax of INR 0.240 million a year ago. Net profit was INR 7.370 million or INR 0.87 basic and diluted per share before and after extraordinary items (not annualized) against net loss of INR 0.240 million or INR 0.08 basic and diluted per share before and after extraordinary items (not annualized) a year ago. For the nine months period, on standalone basis, the company reported total income from operations (net) of INR 175.792 million. Profit from operations before other income, finance cost and exceptional items were INR 7.180 million compared to loss from operations before other income, finance cost and exceptional items of INR 0.535 million a year ago. Loss before ordinary activities before tax was INR 5.572 million against INR 0.535 million a year ago. Net loss was INR 5.572 million or INR 0.66 basic and diluted per share before and after extraordinary items (not annualized) against INR 0.535 million or INR 0.17 basic and diluted per share before and after extraordinary items (not annualized) a year ago. For the quarter, on consolidated basis, the company reported total income from operations (net) of INR 161.608 million against INR 137.283 million for the quarter ended September 30, 2012. Profit from operations before other income, finance cost and exceptional items of INR 24.513 million against INR 10.393 million for the quarter ended September 30, 2012. Profit before ordinary activities before tax and net profit of INR 16.224 million or INR 1.91 basic and diluted per share before and after extraordinary items (not annualized) against loss before ordinary activities before tax and net loss of INR 0.989 million or INR 0.12 basic and diluted per share before and after extraordinary items (not annualized) for the quarter ended September 30, 2012. For the nine months period, on consolidated basis, the company reported total income from operations (net) of INR 408.488 million, profit from operations before other income, finance cost and exceptional items of INR 50.558 million, profit before ordinary activities before tax and net profit of INR 20.393 million or INR 2.39 basic and diluted per share before and after extraordinary items (not annualized).

Parnax Lab Limited, Board Meeting, Feb 14, 2013. Agenda: To approve quarterly results.

Parnax Lab Limited, Board Meeting, Nov 10, 2012. Agenda: To approve unaudited standalone and consolidated earnings results for the second quarter and six months ended September 30, 2012.